‘There’s no such thing as anonymity’: With consumer DNA tests, sperm banks reconsider long-held promises to donors
For generations, it was a basic tenet of donating sperm: Clinics could forever protect their…
Author: STAT
STAT Plus: BIO’s new board chair on the industry’s bad reputation: ‘That’s ridiculous’
WASHINGTON — The sprawling trade association for companies making everything from weed killer to CAR-T…
STAT Plus: National Institute on Aging awards one of the largest federal grants ever for dementia care
The National Institute on Aging has awarded a five-year grant worth up to $53.4 million…
STAT Plus: FDA is inspecting more foreign plants, but fewer domestic facilities
As concerns persist over the safety of medicines made overseas, the Food and Drug Administration…
Apple launching studies testing whether Apple Watch can monitor hearing, mobility, and women’s health
SAN FRANCISCO — Apple on Tuesday announced that it’s launching three research studies that will…
Opinion: What the U.S. can learn from Rwandan refugee camps: treat public health seriously
In 1994, at the tail end of the genocide in Rwanda, I headed to the…
Frontrunner to lead FDA, dogged by controversies, has developed knack for confronting them
WASHINGTON — Before he interviewed with President Trump last week to become Food and Drug…
STAT Plus: Pelosi’s drug pricing plan is more aggressive than expected
WASHINGTON — House Speaker Nancy Pelosi’s plan to lower drug costs is dramatically more aggressive…
Opinion: A view from inside MIT: The Epstein scandal is a teachable moment for colleges and universities
A month after Jeffrey Epstein’s suicide in a Manhattan jail cell, the number of people…
STAT Plus: FDA rejects bid for a moratorium on opioid approvals as scrutiny of the agency heats up
As public health officials struggle to address the ongoing opioid crisis, the Food and Drug…
STAT Plus: Reeling from scandal, Novartis vows to voluntarily release info on manipulated data in the future
Seeking to appease angry regulators, Novartis (NVS) committed to notifying the Food and Drug Administration…
STAT Plus: The bearish view of Acadia Pharma’s antipsychotic drug takes a hit with positive trial results
Did the critics of Acadia Pharmaceuticals — and I’m very much included in that group…
.jpg)
STAT Plus: Pharmalittle: Purdue says talks to settle opioid suits continue; pharma sues to block Canadian pricing regs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Biotech veteran Tony Coles to become CEO of Pfizer neuroscience spinout Cerevel
Tony Coles, remembered by many investors for engineering a $10 billion biotech deal in 2013,…
STAT Plus: Lung cancer drug Lilly bought for $8 billion delivers strong results
The experimental lung cancer drug that led Eli Lilly to spend $8 billion on a…
STAT Plus: Data on Amgen’s KRAS-blocking cancer drug are encouraging, but also raise new questions
Last June, Amgen excited cancer scientists and investors alike with the first tumor-shrinking results from…
STAT Plus: Judge dismisses real estate tycoon’s lawsuit against his son
Joel Marcus, the real estate tycoon credited with helping to turn Cambridge, Mass., into one…
Pneumonia cases linked to vaping are still rising. And federal officials don’t know what’s causing them
The Centers for Disease Control and Prevention reported a rising number of cases of mysterious…
STAT Plus: Genentech reaches deal with JHL Biotech over trade secrets allegedly stolen by former employees
After three of its former employees were arrested last year for allegedly stealing trade secrets…
Some 9/11 firefighters may have higher heart risks now
Firefighters who arrived early or spent more time at the World Trade Center site after…
In an emergency, where ambulances take patients differs by race, study finds
Ambulance crews are generally supposed to take seriously ill patients to the closest hospital that…
Biotech’s ‘distracted boyfriend’ is $3 billion richer. His fellow investors are still waiting for their share
Vivek Ramaswamy, the hedge fund manager turned biotech entrepreneur, was so confident he could make…
STAT Plus: MD Anderson oncologist met with Trump about FDA commissioner job
WASHINGTON — Texas oncologist Dr. Stephen Hahn met with President Trump Wednesday about a potential…
.jpg)
Opinion: 541 report cards show that women are still underrepresented in STEM fields
Despite decades of efforts to increase the number of women working in science, technology, engineering,…
Listen: Pharma existentialism, mainstreaming cyborgs, & FDA palace intrigue
What separates good drug companies from mediocre ones? Have biohackers sold out? And who’s going…
STAT Plus: Cancer drug approvals in the U.S. have surged over the past few decades
Reflecting an intensifying effort to conquer cancer, the portion of new oncology treatments approved by…
STAT Plus: Pharmalittle: Mallinckrodt mulls restructuring as opioid trial nears; the next FDA commissioner will be …
Good morning, everyone, and how you today? We are doing just fine, thank you, since…
STAT Plus: Did a biotech exec crib a New Yorker cartoon?
Plenty of drug company executives have drawn fire for their high salaries or the cost…
Opinion: Hospitals’ new emergency department triage systems boost profits but compromise care
If you’ve needed emergency care in the last few years, you probably encountered this situation:…
STAT Plus: Pharmalittle: U.S. judge rules drug makers must face opioid trial; Purdue threatens bankruptcy
Rise and shine, everyone, another busy day is on the way. And the Pharmalot campus…
Deep-learning AI technique helps scientists see more clearly inside the cell
A version of this story appeared in STAT Health Tech, our weekly newsletter about how…
STAT Plus: It worked in biotech. But can this trade group turn Boston into a hub for digital health?
Boston is the biotech industry’s home base. But in digital health, the city hasn’t kept…
Opinion: Enough with the me-too drugs. New treatments should be worthy of the people who invest their lives in clinical trials
Like many people starting out in the biotech industry, I wanted to make an impact…
STAT Plus: Here are the biopharma companies that launched the most drugs over the past decade
The most important question, when comparing one pharmaceutical company to another, is this: Which is…
STAT Plus: 7 things to know about Aimmune’s peanut allergy therapy ahead of a pivotal FDA meeting
The Food and Drug Administration is bringing together a panel of outside experts to review…
Pfizer’s chessmaster: How a top scientist helped invigorate a lumbering drug giant
In his office at Pfizer’s 42nd Street headquarters in Manhattan, Chief Scientific Officer Mikael Dolsten…
STAT Plus: Pharmalittle: Some states object to Purdue opioid deal; top pharma CEOs donate to key Republicans
Good morning, everyone, and welcome to another working week. We hope the extended respite —…
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Vertex Pharmaceuticals announced Tuesday that it plans to acquire an ambitious startup for $950 million,…
STAT Plus: New Sanofi CEO wants to tap digital technology to improve drug research and sales
Paul Hudson, who started as CEO of Sanofi Monday, believes there is “magic” to be…
Opinion: The FDA and Sarepta: a window into the real world of drug regulation
It is hard to discern the true state of drug regulation from the outside, but…
As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash
WASHINGTON — Top pharmaceutical CEOs have targeted a small group of Republican senators with roughly…
STAT Plus: Chinese scientists came to the U.S. to pursue their dreams. Under tighter scrutiny, many are returning home
At the dawn of the new millennium, Ting Han, a graduate of Tsinghua University in Beijing,…
Canine MRIs sniff out how human preferences shaped dogs’ hallmark traits
Science has spoken: Getting a border collie to stop herding city pigeons or a Doberman…
STAT Plus: AI system can create novel drug candidates in just 46 days, study finds
It often takes years and hundreds of millions of dollars to discover a novel drug…
‘I propose that we grow up a little bit’: Biohackers grapple with when to reject mainstream science — and when to embrace it
LAS VEGAS — Biohackers have gained notoriety with provocative stunts like injecting themselves with CRISPR,…
Doctors are more likely to prescribe opioids later in the day — or if appointments run late
After seeing dozens of patients in a hectic and long day in the clinic, when…
STAT Plus: Pharmalittle: Hormone therapy link to breast cancer strengthened; where did Sacklers’ Purdue money end up?
Good morning. Elizabeth Cooney here, holding down the remote Pharmalot fort in Boston as offices…
STAT Plus: Executive draws on his career experience (literally)
WALTHAM, Mass. — For many biotech executives, an invitation to speak at the annual J.P….
Opinion: Animal activists are on the wrong side of the fight against AIDS
AIDS could soon be history. Johnson & Johnson recently announced plans to test an experimental…
Opinion: Every hospital needs ‘recovery coaches’ for patients with substance use problems
Families of loved ones treated in our emergency department for overdoses or other substance use…